this review of the literature and our own data indicate that use of high-dose , progestogen-dominant ocs induces a potentially atherogenic lipoprotein profile ( high low-density lipoprotein-cholesterol : high-density lipoprotein-cholesterol ratio ) , mostly attributable to the antiestrogenic action of the progestogen content of these ocs .
C0008377
cholesterol
C0023822
high-density lipoprotein-cholesterol